CPHI Milan 2026
10/2026 – 10/2026
Sobre la Empresa
- Nombre legal: Yuxi Walvax Biotechnology Co., Ltd.
- País de registro: China
- Dirección: 83 South Dongfeng Road, Yuxi • Yunnan
- Número de empleados: 1000 - 4999
- Año de fundación: 2001
Descripción:
Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in researching, developing, manufacturing and distributing safe, efficacious human vaccines. A leading publicly listed company in China, Walvax has successfully developed 9 licensed vaccines (13 presentations), including the world's 2nd approved PCV-13 vaccine, 4th approved mRNA COVID-19 vaccine, and 5th approved HPV vaccine.
Actividades Comerciales
Productos Biofarmacéuticos
ExportadorFabricante
Clasificación ATC (Anatómica, Terapéutica, Química)
Fabricante
Mercados de Venta
- South Asia: Bangladesh, India
- Mainland Southeast Asia: Indonesia, Philippines
- Central Asia: Kyrgyzstan, Uzbekistan
- Northern Africa: Egypt, Morocco
- Western Africa: Nigeria, Senegal
Productos/Servicios Clave
- Productos Biofarmacéuticos: R&D Research and Development, Vaccines, 13-valent pneumococcal conjugate vaccine, Paediatric combination vaccines, Walrinvax meningococcal vaccine
- Clasificación ATC (Anatómica, Terapéutica, Química): 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine, 23-valent Pneumococcal Polysaccharide Vaccine
Nuestros Productos & Servicios
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Proofs
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario